Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00900575 · ClinicalTrials.gov registry record · NA
Cervical Cancer Detection Using Optical Spectroscopy
A NA study of Cervical Cancer, sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 1
- Study location
NCT00900575 is a NA study of Cervical Cancer that is actively recruiting participants, run by Duke University. The registered enrollment target is 350 participants, below the 568-participant average among 144 other Cervical Cancer trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00900575, a NA study of Cervical Cancer, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the work described in this protocol is to determine the optical signatures of cervical dysplasia using optical technologies.
Conditions Studied
Interventions
- DEVICE Optical Spectroscopy Bench-Top System
- DEVICE Portable Optical Spectrometer
- DEVICE Transvaginal colposcope
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2006-05 |
| Est. Completion | 2028-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00900575
The ClinicalTrials.gov registry entry for NCT00900575 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 568-participant average among 144 other Cervical Cancer trials with a reported enrollment target (38% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cervical Cancer appearing as the primary indexed condition, and to 3 interventions - of which Optical Spectroscopy Bench-Top System is the first listed.
NCT00900575 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT00900575 about?
NCT00900575 is a clinical study titled "Cervical Cancer Detection Using Optical Spectroscopy". The objective of the work described in this protocol is to determine the optical signatures of cervical dysplasia using optical technologies.
What is the current status of trial NCT00900575?
This trial is currently recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2006-05. Estimated completion is 2028-01-31.
What conditions does trial NCT00900575 study?
This clinical trial studies the following conditions: Cervical Cancer.
What interventions are being tested in trial NCT00900575?
The interventions under investigation include: Optical Spectroscopy Bench-Top System (DEVICE), Portable Optical Spectrometer (DEVICE), Transvaginal colposcope (DEVICE).
Who is sponsoring clinical trial NCT00900575?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00900575 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama
RECRUITING · NA
-
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.